Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emilia Tarland"'
Autor:
Yann Gager, Emilia Tarland, Dietmar Lieckfeldt, Matthieu Ménage, Fidel Botero-Castro, Stephen J Rossiter, Robert H S Kraus, Arne Ludwig, Dina K N Dechmann
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150780 (2016)
A fundamental condition for any work with free-ranging animals is correct species identification. However, in case of bats, information on local species assemblies is frequently limited especially in regions with high biodiversity such as the Neotrop
Externí odkaz:
https://doaj.org/article/638b92717d9a452da5f4662d432c309e
Autor:
Emilia Tarland, Jan Brosda
Publikováno v:
Behavioural Brain Research. 345:13-20
The olfactory system participates in many sensory processes, and olfactory endophenotypes appear in a variety of neurological disorders such as Alzheimer's and Parkinson's disease, depression and schizophrenia. Social withdrawal is a core negative sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66062b798d659181c29485ec5473ae37
https://doi.org/10.1016/j.bbr.2018.02.023
https://doi.org/10.1016/j.bbr.2018.02.023
Publikováno v:
Psychopharmacology. 235:99-108
Rationale 2-Bromoterguride, a dopamine D2 receptor partial agonist with antagonist properties at serotonin 5-HT2A receptors and α2C-adrenoceptors, meets the prerequisites of a putative atypical antipsychotic drug (APD). We recently showed that 2-bro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ab2a3cf8e0b61b56cc1607097fa3c54
https://doi.org/10.1007/s00213-017-4747-x
https://doi.org/10.1007/s00213-017-4747-x
Publikováno v:
Psychopharmacology
Rationale Recently, we showed that 2-bromoterguride acted as a dopamine D2 receptor partial agonist, a serotonin 5-HT2A and α2C-adrenergic receptor antagonist, and exhibited antidopaminergic efficacy in amphetamine-induced locomotion (AIL) in rats w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad0bae2f303798d448b4c170966319e
http://europepmc.org/articles/PMC4933731
http://europepmc.org/articles/PMC4933731